FDA recall D-0558-2024 · initiated May 22, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,